Sunny Malhotra Sareen I am a biomedical researcher who serves as the Principal Investigator at the Clinical Neuroimmunology Unit of the Vall d'Hebron Research Institute. Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Sunny Malhotra Sareen LinkedIn Twitter Orcid Email Institutions of which they are part Main researcher Clinical Neuroimmunology Vall Hebron Institut de Recerca I am a biomedical researcher who serves as the Principal Investigator at the Clinical Neuroimmunology Unit of the Vall d'Hebron Research Institute.
As the Principal Investigator, I have a strong commitment to Translational Research and a solid background in biomedical sciences. My expertise lies in the discovery of biomarkers through genetic indicators and gene expression, particularly in identifying new therapeutic targets for neurological diseases. Additionally, I have over a decade of involvement in pharmacogenetics, genomics, and inflammasome biology studies. I have received training from various institutions, including the National Institute of Immunology (New Delhi), the Institute of Genomics and Integrative Biology (New Delhi), Progenika Biopharma, and UKE Hamburg. Dr. Malhotra has developed research lines funded by the Carlos III Health Institute during the periods 2017-2019 and 2021-2024. Selected awards/grants granted to the PI include: "Novartis Award" for the best oral communication; "Extraordinary Award" of the year for his "Doctorate" (UPF); "Merck Solidarity Award" for multiple sclerosis of the year; "Hope Award" for multiple sclerosis of the year; "Marie Curie Fellowship": as a predoctoral researcher; "Educational Fellowship": from ECTRIMS (Boston); "PERIS Fellowship": as a postdoctoral researcher. I serve as a lecturer and have extensive experience reviewing research articles in international journals. I am a member of various scientific editorial committees and have supervised master's and doctoral theses with 'Cum Laude' honors. I am a member of the Human Resources Strategy for Researchers (HRS4R) Committee at the center, with the main motto of promoting excellence in science in Europe. In general, my primary research focus includes neuroinflammatory/neurodegenerative diseases and the search for new biomarkers/therapeutic target objectives and drug discovery.
Projects Estudio del papel del inflamasoma en pacientes con esclerosis múltiple IP: Manuel Comabella Lopez Collaborators: Sunny Malhotra Sareen, Miriam Izquierdo Sans Funding agency: Generalitat de Catalunya - Departament de Salut Funding: 103807.4 Reference: SLT002/16/00357 Duration: 04/04/2017 - 31/12/2019 Estudio del papel del inflamasoma en pacientes con esclerosis múltiple.. IP: Sunny Malhotra Sareen Collaborators: Jordi Rio Izquierdo, Angela Vidal Jordana Funding agency: Instituto de Salud Carlos III Funding: 72600 Reference: PI16/00924 Duration: 01/01/2017 - 31/12/2020 Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC) IP: Xavier Montalban Gairín Collaborators: Susana Otero Romero, Carlos Nos Llopis, Sunny Malhotra Sareen, José Ant. Graells Salvador, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Margarida Capell Maymo, Silvia Soler García, Carmen Tur Gomez, Jordi Barquinero Mañez, Herena Eixarch Ahufinger, Carme Santoyo Medina, Oriol Nualart Mundo, Mar Tintore Subirana, M Jesus Arevalo Navines, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Sergio Vergara Ruiz, Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC), Joaquin Castillo Justribo, Milagros Fraga Pereira, Breogan Rodriguez Acevedo, Mireia Castillo Juarez, Nicolás Miguel Fissolo, Georgina Arrambide García Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 50000 Reference: 2014 SGR 1082 Duration: 01/01/2014 - 31/12/2016 Biological markers for rationalizing treatment decisions in Multiple Sclerosis (BEST-MS) Grand Agreement nº 305477 IP: Manuel Comabella Lopez Collaborators: Sunny Malhotra Sareen, Jordi Rio Izquierdo, Xavier Montalban Gairín Funding agency: EUROPEAN COMMISSION Funding: 424320 Reference: BEST-MS_FP7HEALTH2012 Duration: 01/11/2012 - 31/10/2016 Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Page 4 Next page › Last page »
